CD8A and Sepsis: In this series of investigations, we found that CXCR4 blockade improved survival in murine polymicrobial sepsis, increased the absolute number of circulating CD4+ and CD8+ T cells, and mitigated sepsis-induced T cell exhaustion phenotypes.